Pliant Therapeutics to Participate in Needham Healthcare Conference
SOUTH SAN FRANCISCO, Calif., April 05, 2022 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX),…
SOUTH SAN FRANCISCO, Calif., April 05, 2022 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX),…
LAS VEGAS, April 05, 2022 (GLOBE NEWSWIRE) — CLS Holdings USA, Inc. (OTCQB:CLSH) (CSE:CLSH), the…
– Total Product Revenues Expected in the Range of $450.0 million to $465.0 million –…
XMT-1660 demonstrates robust activity in preclinical models of breast cancer XMT-2056 demonstrates robust activity as…
–Seasoned physician, scientist and life science executive brings expertise in clinical research and development across…
LONDON, April 05, 2022 (GLOBE NEWSWIRE) — Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical…
A Potential Multi-Billion Dollar Global Market Opportunity for Cancer Treatments MONTREAL, April 05, 2022 (GLOBE…
CAMBRIDGE, Mass., April 05, 2022 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”) a…
BELTSVILLE, Md., April 05, 2022 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical…
CARMEL, Ind., April 05, 2022 (GLOBE NEWSWIRE) — MBX Biosciences, Inc., a clinical stage biopharmaceutical…
Dr. Mellion brings deep experience in neuromuscular disease research and treatment as a biopharma executive,…
WINNIPEG, Manitoba, April 05, 2022 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the…
SEATTLE, April 05, 2022 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY), the IgA Nephropathy…
Dr. Min will lead global clinical development and regulatory strategy MIAMI, April 05, 2022 (GLOBE…
Focus: RAD011, an investigational synthetic cannabidiol oral solution Webcast details: 10:00am to 12:00pm for current…
Interim analysis performed with initial 150 U.S. patient samples enrolled in its prospective multicenter trial…
CAMBRIDGE, Mass., April 05, 2022 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq: GBIO), a biotechnology…
Brand Pura H&W™ Brand Pura H&W™ The exclusive distribution agreement includes 5 SKUs from Pura…
LTX-315’s novel mechanism of action directly targets cancerous skin cells to induce an anti-tumor immune…
TORONTO, April 05, 2022 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB:…